BrainStorm Cell Therapeutics
BCLI
#9921
Rank
S$14.21 M
Marketcap
$2.49
Share price
3.08%
Change (1 day)
-40.66%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Cash on Hand

Cash on Hand as of September 2024 : S$0.22 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company has S$0.22 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

BrainStorm Cell Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31S$3.99 M-86.61%
2021-12-31S$29.86 M-46.16%
2020-12-31S$55.47 M7132.14%
2019-12-31S$0.76 M-92.05%
2018-12-31S$9.65 M-6.97%
2017-12-31S$10.37 M-28.25%
2016-12-31S$14.45 M-35.94%
2015-12-31S$22.56 M99.98%
2014-12-31S$11.28 M154.28%
2013-12-31S$4.43 M-11.18%
2012-12-31S$4.99 M100.64%
2011-12-31S$2.49 M1978.87%
2010-12-31S$0.11 M8433.03%
2009-12-31S$0 M-50.92%
2008-12-31S$0 M-97.69%
2007-12-31S$0.12 M34.51%
2006-12-31S$0.09 M
2006-03-31S$0.46 M-46.03%
2005-03-31S$0.86 M11171.5%
2004-03-31S$0 M-56.33%
2003-03-31S$0.01 M-73.55%
2002-03-31S$0.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
S$6.80 B 2,998,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.36 B 602,096.43%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.67 B 736,203.57%๐Ÿ‡บ๐Ÿ‡ธ USA
S$2.29 B 1,011,328.57%๐Ÿ‡บ๐Ÿ‡ธ USA
S$60.48 M 26,557.14%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA